Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
PLoS Pathog ; 9(2): e1003188, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23468627

ABSTRACT

Influenza viruses (IV) cause pneumonia in humans with progression to lung failure and fatal outcome. Dysregulated release of cytokines including type I interferons (IFNs) has been attributed a crucial role in immune-mediated pulmonary injury during severe IV infection. Using ex vivo and in vivo IV infection models, we demonstrate that alveolar macrophage (AM)-expressed IFN-ß significantly contributes to IV-induced alveolar epithelial cell (AEC) injury by autocrine induction of the pro-apoptotic factor TNF-related apoptosis-inducing ligand (TRAIL). Of note, TRAIL was highly upregulated in and released from AM of patients with pandemic H1N1 IV-induced acute lung injury. Elucidating the cell-specific underlying signalling pathways revealed that IV infection induced IFN-ß release in AM in a protein kinase R- (PKR-) and NF-κB-dependent way. Bone marrow chimeric mice lacking these signalling mediators in resident and lung-recruited AM and mice subjected to alveolar neutralization of IFN-ß and TRAIL displayed reduced alveolar epithelial cell apoptosis and attenuated lung injury during severe IV pneumonia. Together, we demonstrate that macrophage-released type I IFNs, apart from their well-known anti-viral properties, contribute to IV-induced AEC damage and lung injury by autocrine induction of the pro-apoptotic factor TRAIL. Our data suggest that therapeutic targeting of the macrophage IFN-ß-TRAIL axis might represent a promising strategy to attenuate IV-induced acute lung injury.


Subject(s)
Acute Lung Injury/metabolism , Influenza, Human/metabolism , Interferon-beta/metabolism , Macrophages, Alveolar/metabolism , Pneumonia, Viral/metabolism , Respiratory Mucosa/metabolism , Acute Lung Injury/immunology , Acute Lung Injury/pathology , Adult , Animals , Apoptosis , Disease Models, Animal , Humans , Influenza, Human/immunology , Influenza, Human/pathology , Macrophages, Alveolar/immunology , Macrophages, Alveolar/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Mosaicism , Pneumonia, Viral/immunology , Pneumonia, Viral/pathology , Respiratory Mucosa/immunology , Respiratory Mucosa/pathology , TNF-Related Apoptosis-Inducing Ligand/metabolism
3.
J Immunol ; 188(2): 811-7, 2012 Jan 15.
Article in English | MEDLINE | ID: mdl-22156592

ABSTRACT

Streptococcus pneumoniae is the leading cause of community-acquired pneumonia. In this study, we examine an innate immune recognition pathway that senses pneumococcal infection, triggers type I IFN production, and regulates RANTES production. We found that human and murine alveolar macrophages as well as murine bone marrow macrophages, but not alveolar epithelial cells, produced type I IFNs upon infection with S. pneumoniae. This response was dependent on the pore-forming toxin pneumolysin and appeared to be mediated by a cytosolic DNA-sensing pathway involving the adapter molecule STING and the transcription factor IFN regulatory factor 3. Indeed, DNA was present in the cytosol during pneumococcal infection as indicated by the activation of the AIM2 inflammasome, which is known to sense microbial DNA. Type I IFNs produced by S. pneumoniae-infected macrophages positively regulated gene expression and RANTES production in macrophages and cocultured alveolar epithelial cells in vitro. Moreover, type I IFNs controlled RANTES production during pneumococcal pneumonia in vivo. In conclusion, we identified an immune sensing pathway detecting S. pneumoniae that triggers a type I IFN response and positively regulates RANTES production.


Subject(s)
Chemokine CCL5/biosynthesis , Interferon Regulatory Factor-3/physiology , Interferon Type I/biosynthesis , Macrophages, Alveolar/immunology , Membrane Proteins/physiology , Respiratory Mucosa/immunology , Streptococcus pneumoniae/immunology , Animals , Autocrine Communication/immunology , Bacterial Proteins/physiology , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Coculture Techniques , Cytosol/immunology , Cytosol/metabolism , DNA, Bacterial/immunology , DNA, Bacterial/metabolism , Disease Models, Animal , Humans , Immunity, Innate , Interferon Type I/physiology , Lung/cytology , Lung/immunology , Lung/metabolism , Macrophages, Alveolar/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Paracrine Communication/immunology , Respiratory Mucosa/cytology , Respiratory Mucosa/metabolism , Signal Transduction/genetics , Signal Transduction/immunology , Streptolysins/physiology
4.
J Virol ; 84(4): 2122-33, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20007264

ABSTRACT

A reassortant avian influenza virus (designated FPV NS GD), carrying the NS-segment of the highly pathogenic avian influenza virus (HPAIV) strain A/Goose/Guangdong/1/96 (GD; H5N1) in the genetic background of the HPAIV strain A/FPV/Rostock/34 (FPV; H7N1), was rescued by reverse genetics. Remarkably, in contrast to the recombinant wild-type FPV (rFPV), the reassortant virus was able to replicate more efficiently in different human cell lines and primary mouse epithelia cells without prior adaptation. Moreover, FPV NS GD caused disease and death in experimentally infected mice and was detected in mouse lungs; in contrast, rFPV was not able to replicate in mice effectively. These results indicated an altered host range and increased virulence. Furthermore FPV NS GD showed pronounced pathogenicity in chicken embryos. In an attempt to define the molecular basis for the apparent differences, we determined that NS1 proteins of the H5N1 and H7N1 strains bound the antiviral kinase PKR and the F2F3 domain of cleavage and polyadenylation specificity factor 30 (CPSF30) with comparable efficiencies in vitro. However, FPV NS GD infection resulted in (i) increased expression of NS1, (ii) faster and stronger PKR inhibition, and (iii) stronger beta interferon promoter inhibition than rFPV. Taken together, the results shed further light on the importance of the NS segment of an H5N1 strain for viral replication, molecular pathogenicity, and host range of HPAIVs and the possible consequences of a reassortment between naturally occurring H7 and H5 type HPAIVs.


Subject(s)
Influenza A Virus, H5N1 Subtype/physiology , Influenza A Virus, H5N1 Subtype/pathogenicity , Influenza A virus/physiology , Influenza A virus/pathogenicity , Viral Nonstructural Proteins/physiology , Animals , Base Sequence , Birds , Cell Line , Chick Embryo , DNA, Viral/genetics , Dogs , Female , Genes, Viral , Humans , Influenza A Virus, H5N1 Subtype/genetics , Influenza A virus/genetics , Interferon-beta/biosynthesis , Mice , Mice, Inbred C57BL , Reassortant Viruses/genetics , Reassortant Viruses/pathogenicity , Reassortant Viruses/physiology , Viral Nonstructural Proteins/genetics , Virulence/genetics , Virulence/physiology , Virus Replication/genetics , Virus Replication/physiology , eIF-2 Kinase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...